智云健康在港交所上市，保持初心，始终以患者为中心，致力于让数字健康走进千家万户。截至2022年12月31日，合作医院逾2500家，合作药店逾19.3万家，注册用户约2850万 ClouDr has been listed on the Hong Kong Stock Exchange, maintaining its original mission, and always focusing on the patients. We are committed to bringing digital health into millions of households. As of December 31, 2022, we have partnered with over 2,500 hospitals and 193,000 pharmacies, with approximately 28.5 million registered users.
双SaaS系统、智云健康APP、智云医生APP等产品矩阵，已形成“医患药付”一站式慢病管理生态，公司实现自我造血，获得市场认可 The dual SaaS system, ClouDr APP, Dr ClouDr and other product matrices have formed a one-stop chronic disease management ecosystem of "doctors, patients, drug, payment". ClouDr has achieved self-growth and gained market recognition.
合作医院近1000家，业务收入实现300%的增长 Close to 1,000 partner hospitals; 300% growth in revenues Team expanded with many talents from leaders in the medical and internet industries, such as Johnson & Johnson, Kanghong Pharmaceutical, and Alibaba, among others
吸引大批来自强生、康弘药业、阿里巴巴等医疗与互联网头部公司优秀人才加入
